Effect of Tirofiban on Recovery of Coronary Flow and Myocardial Blush Perfusion in Patients with Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention

杨新春,徐立,王乐丰,葛永贵,王红石,丁枭伟,王文君,邹阳春,李惟铭,刘宇
2006-01-01
Abstract:Objective:To investigate the effect of glycoprotein Ⅱb/Ⅲa receptor blockade with tirofiban on coronary flow and myocardial blush perfusion recovery in patients with acute myocardial infarction (AMI) treated by primary percutaneous coronary intervention (PCI). Methods:With mean age of 60.2±19.1 years old,50 patients (34 males) with first AMI were randomized to receive either tirofiban and primary PCI (n=25) or primary PCI alone (n=25).Baseline characteristics of the two groups were compared. TIMI grade,Corrected TIMI frame count (CTFC) and myocardial blush grade were studied immediately after P-PCI. Results:There was no signifcant difference between the two groups in basic clinical or angiographic characteristics before PCI (P>0.05).There was no difference between the two groups in percentage of TIMI 3 flow achieved in IRAs after PCI (96% vs 88%,P>0.05).Fewer TIMI frames (22.8±8.9 frames vs.30.9±3.4 frames,P<0.05) and higher percentage of blush grade 3 of IRAs (72.0% vs 32.0%,P<0.01) were achieved in tirofiban group.Follow-up data before discharge showed there were lower peak serum CK levels (1862.9±301.0 IU/L vs 2302.3±582.6 IU/L,P<0.05) and faster ST segment resolution in the tirofiban group after PCI (63.2±13.3% vs 40.9±12.9%,P<0.05).There was no significant difference between the two groups in occurrence of MACE or bleeding in both groups (P>0.05). Conclusions:Application of tirofiban during primary PCI in patients with AMI was safe and effective,which improves micro- vascular perfusion,and further study is necessary to reveal the real effect of tirofiban on clinical results in AMI patients treated by primary PCI.
What problem does this paper attempt to address?